Morgan Stanley raised the firm’s price target on Patterson-UTI (PTEN) to $19 from $18 and keeps an Overweight rating on the shares after the company announced plans to merge with NexTier Oilfield (NEX). Robust cost-out and operational efficiency-related synergy targets seem achievable, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on PTEN:
- Patterson-UTI price target raised to $13 from $12 at Citi
- NexTier Oilfield downgraded to Neutral from Buy at Citi
- Patterson-UTI, NexTier to join in merger of equals with $5.4B enterprise value
- Patterson-UTI Energy and NexTier Oilfield Solutions to Combine in Merger of Equals, Creating Industry Leading Drilling and Completions Services Provider
- Patterson-UTI holders likely more excited over deal talks, JPMorgan says